Questcor Pharmaceuticals: Risky, But Cheap [View article]
Indeed, Vigabatrin (marketed as Sabril in the U.S. by Lundbeck) was approved by the FDA at the end of August and became commercially available September 21. It is the first officially approved FDA treatment for IS.
Questcor Pharmaceuticals: Risky, But Cheap [View article]
Thanks for the comments.